Clinical Trials Logo

Birth Weight clinical trials

View clinical trials related to Birth Weight.

Filter by:

NCT ID: NCT01375309 Completed - Preterm Infants Clinical Trials

Bifidobacterium Supplementation for Very Low Birth Weight Infants

Bifido(RCT)
Start date: January 2010
Phase: N/A
Study type: Interventional

Probiotic supplementation to preterm infants have been reported to be beneficial in neonatal intensive care unit (NICU). Our pilot study also showed accelerated feeding in preterm infants who received Bifidobacterium bifidum early after birth. In order to evaluate these beneficial effects of Bifidobacterium bifidum, a prospective randomized control study is conducted. The hypothesis of the study is that Bifidobacterium bifidum supplementation to preterm infants improve enteral feeding and growth in very low birth weight infants.

NCT ID: NCT01363167 Completed - Clinical trials for Vitamin D Deficiency

Identifying Vitamin D Deficiency in Very Low Birth Weight Infant (VLBW) Infants Part 2

Start date: October 2011
Phase: N/A
Study type: Interventional

This study is to determine the amount of vitamin D required for a very low birth weight infant to reach vitamin D sufficiency and achieve optimal calcium health and bone growth.

NCT ID: NCT01360528 Completed - Clinical trials for Very Low Birth Weight Baby

Serum Folic Acid Levels in Preterm Infants

FALIPI
Start date: February 2011
Phase: N/A
Study type: Observational

Therefore preterm infants must need folic acid replacement than term babies.

NCT ID: NCT01353313 Active, not recruiting - Clinical trials for Bronchopulmonary Dysplasia

Hydrocortisone for BPD

Start date: August 11, 2011
Phase: Phase 3
Study type: Interventional

The Hydrocortisone and Extubation study will test the safety and efficacy of a 10 day course of hydrocortisone for infants who are less than 30 weeks estimated gestational age and who are intubated at 14-28 days of life. Infants will be randomized to receive hydrocortisone or placebo. This study will determine if hydrocortisone improves infants'survival without moderate or severe BPD and will be associated with improvement in survival without moderate or severe neurodevelopmental impairment at 22 - 26 months corrected age.

NCT ID: NCT01350765 Completed - Neonatal Sepsis Clinical Trials

Naushero Feroze Neonatal Survival Project

AKU
Start date: March 2010
Phase: N/A
Study type: Interventional

The present study will be carried out in close collaboration with the National Program for Lady Health Workers, a Ministry of Health program with 100,000 Lady Health Workers covering 60% of the rural population of Pakistan. A team of Lady Health Workers and a Traditional Birth Attendant will provide care to the mothers and newborns at household level. A Basic Health Unit will take care of non complicated referrals and provide injectable antibiotics for neonatal sepsis. Complicated (definitions given in methods section) cases will be referred by the LHWs/BHUs to the District Headquarter Hospital which will have a functioning neonatal care unit. The District Health Services, Naushero Feroz, Provincial Department of Health, Sindh and the Federal Ministry of Health are study collaborators, therefore, guaranteeing scaling up of interventions at national level. Hypothesis: In comparison to a basic package of existing training program of LHWs, enhanced training of LHWs and TBAs in the early recognition and management of birth asphyxia, serious newborn infections and LBW (combined with prompt referral) will result in an additional 30% reduction in neonatal mortality.

NCT ID: NCT01344616 Completed - Preterm Birth Clinical Trials

Reducing Preterm Births in Underserved Pregnant Women

Start date: August 2010
Phase: Phase 2
Study type: Interventional

Timely screening and management of modifiable conditions can reduce preterm births, yet providing effective prenatal risk management systems to meet the unique needs of medically underserved populations is complex. If the proposed system proves to be effective in reducing preterm births it can improve maternal and child quality of life as well as reduce the economic burden of preterm births in the U.S.

NCT ID: NCT01341236 Completed - Clinical trials for Infant, Very Low Birth Weight

Near Infrared Spectroscopy (NIRS) and Superior Mesenteric Artery (SMA) Doppler Patterns as Predictor of Feeding Tolerance in Very Low Birth Weight (VLBW) IntraUterine Growth Restricted (IUGR) and NON IUGR Infants

Start date: September 2011
Phase: Phase 4
Study type: Interventional

This study aims at recruiting about twenty very low birth weight infants, either intrauterine growth restricted (IUGR) or NON-IUGR STRATIFICATION:Population will be stratified in two groups: IUGR infants (approximately 10 children) and NON-IUGR infants (approximately 10 children). PRIMARY ENDPOINT:To evaluate the changes in the intestinal perfusion determined by feeding in VLBW infants fed by 3 hours nasogastric nutrition (CN) or by bolus (BN). SECONDARY ENDPOINT: - To compare if changes in the intestinal perfusion induced by feeding are different between IUGR and NON-IUGR infants; - To compare growth and nutritional status of the 2 groups by randomized arm. - To evaluate if changes of intestinal perfusion and oximetry induced by feeding are related to baseline (< 72 hours of life) values of Doppler flow velocimetry and of Near Infrared Spectroscopy (NIRS). After birth, in the first 24 hours of life, and in the transitional period, between the 48th and 72nd hours of life, all infants' intestinal perfusion will be evaluated with NIRS and a doppler of the superior mesenteric artery will be executed. - To test if changes in intestinal oximetry and perfusion can be reliable predictors of feeding intolerance (need of interruption of enteral feeding). DESIGN: This is a randomized, non-pharmacological, single-center, cross-over study including 20 VLBW babies. Duration of the study: 24 months. INCLUSION CRITERIA - Weight at birth ranging: 700 - 1501 grams; - Gestational age up to 25 weeks and 6 days; - Written informed consent from parents or guardians EXCLUSION CRITERIA - Major congenital abnormality (severe heart or cerebral disease, chromosomopathies, severe renal malformations, any malformation or disease of the gastroenteric tract) - Significant multi-organ failure prior to trial entry (perinatal asphyxia with renal, cardiac or cerebral impairment, DIC) - Pre-existing cutaneous disease not allowing the placement of the probe

NCT ID: NCT01335919 Withdrawn - Infant, Newborn Clinical Trials

Neonatal Non-Invasive Hemoglobin Determination

Start date: September 2011
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate hemoglobin (Hgb) measurement by Masimo-developed pulse co-oximetry in pediatric patients weighing less than 3 kilograms (Kg).

NCT ID: NCT01335490 Completed - Pneumonia Clinical Trials

Intervening to Improve Infant Health in Ghana

Start date: August 2013
Phase: N/A
Study type: Interventional

The purpose of the study is to understand how cooking might affect the health of pregnant women and their babies. The goal of the research is to determine whether, interventions in decreasing exposure to smoke from cook stoves can bring about a significant change in the indoor air pollution levels and health of communities in Ghana. Hypothesis 1. Use of improved cook stoves starting by the third trimester pregnancy will lead to a significant increase in average birth weight in newborns. Hypothesis 2. Use of improved cook stoves will lead to a significant reduction in the rate of severe acute lower respiratory disease during the first 12 months of life.

NCT ID: NCT01330095 Completed - Preterm Infants Clinical Trials

Early Administration of Bifidobacterium to Very Low Birth Weight Infants

Start date: March 2007
Phase: N/A
Study type: Interventional

To evaluate the effects of early administration of probiotics on acceleration of enteral feeding, and on growth of very low birth weight infants, newborn infants with birth weight less than 1500g are administered Bifidobacterium bifidum twice a day.